AngioDynamics Inc. (ANGO)
NASDAQ: ANGO
· Real-Time Price · USD
11.72
-0.11 (-0.93%)
At close: Oct 16, 2025, 3:59 PM
11.61
-0.94%
After-hours: Oct 16, 2025, 05:26 PM EDT
-0.93% (1D)
| Bid | 11.15 |
| Market Cap | 480.3M |
| Revenue (ttm) | 300.72M |
| Net Income (ttm) | -32.1M |
| EPS (ttm) | -0.78 |
| PE Ratio (ttm) | -15.03 |
| Forward PE | -34.58 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 12.38 |
| Volume | 716,315 |
| Avg. Volume (20D) | 503,879 |
| Open | 11.90 |
| Previous Close | 11.83 |
| Day's Range | 11.69 - 12.20 |
| 52-Week Range | 6.11 - 13.50 |
| Beta | 0.78 |
| Ex-Dividend Date | n/a |
About ANGO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANGO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANGO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAngioDynamics Inc. is scheduled to release its earnings on
Jan 7, 2026,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+6.05%
AngioDynamics shares are trading higher after the ...
Unlock content with
Pro Subscription
3 months ago
-10.18%
ANGO stock has given up its prior gain. AngioDynamics shares were trading higher after the company reported better-than-expected Q4 financial results and issued FY26 revenue guidance above estimates.
2 weeks ago · seekingalpha.com
AngioDynamics: Discounted Sales Multiple With Real Growth EnginesAngioDynamics, Inc. remains a Buy, trading at a steep discount to peers despite double-digit MedTech growth and improving margins. ANGO's Med Tech division now drives 47% of sales, with strong perform...
2 weeks ago · seekingalpha.com
Wall Street Week AheadListen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.